First AD

Second AD

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Evolving Approaches in the Management of Neuroendocrine Tumor-Associated Carcinoid Syndrome

Dr Pommier discusses key safety, efficacy, and quality of life data from the TELEPATH trial investigating the tryptophan hydroxylase inhibitor telotristat ethyl, while Dr Das comments on real-world data complements to the trial.

Data from the TELEPATH Trial and Real-World Analyses

Overview of Neuroendocrine Tumors (NETs)

Overview of Carcinoid Syndrome (CS)

Overview of Carcinoid Heart Disease (CHD)

Management of Carcinoid Syndrome-Related Symptoms

Diagnosis and Management of Somatostatin Analog-Refractory Carcinoid Syndrome

Available Treatment Options for Somatostatin Analog-Refractory Carcinoid Syndrome

Prevention, Treatment, and Management of Carcinoid Heart Disease

Unmet Needs for Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome

Advice for Community Physicians Treating Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome